one8zero8 LLC’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.05M Sell
33,730
-100
-0.3% -$5.83K 0.46% 57
2025
Q4
$1.82M Sell
33,830
-1,255
-4% -$60.4K 0.4% 65
2025
Q3
$1.58M Sell
35,085
-41
-0.1% -$1.92K 0.34% 69
2025
Q2
$1.63M Sell
35,126
-38
-0.1% -$1.86K 0.38% 64
2025
Q1
$2.14M Sell
35,164
-212
-0.6% -$12.4K 0.51% 50
2024
Q4
$2M Buy
+35,376
New +$1.98M 0.43% 55

Other funds holding BMY

one8zero8 LLC's BMY Position: Q1 2026 in Review

one8zero8 LLC reduced its Bristol-Myers Squibb (BMY) stake by 0.3% in Q1 2026, selling an estimated $5.83K and leaving 33,730 shares worth $2.05M. The position accounts for 0.46% of the portfolio, ranked #57.

one8zero8 LLC first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.14M in Q1 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • one8zero8 LLC held 33,730 shares of Bristol-Myers Squibb worth $2.05M as of Q1 2026.
  • one8zero8 LLC sold 100 Bristol-Myers Squibb shares in Q1 2026, an estimated $5.83K.
  • Bristol-Myers Squibb made up 0.46% of one8zero8 LLC's portfolio in Q1 2026, its #57 holding.
  • one8zero8 LLC first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
  • one8zero8 LLC's Bristol-Myers Squibb position peaked at $2.14M in Q1 2025.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on one8zero8 LLC's 13F filing for Q1 2026, filed 7 May 2026.